Profile
Shannon Inman worked as Vice President-Global Clinical Operations at Genprex, Inc. from 2020 to 2021.
Prior to that, she worked as Vice President-Global Clinical Operations at Kuur Therapeutics Ltd.
She also worked as a Project Manager at Baylor College of Medicine.
In terms of education, Inman received an undergraduate degree from Texas A&M University.
Former positions of Shannon Inman
| Companies | Position | End |
|---|---|---|
| GENPREX, INC. | Chief Tech/Sci/R&D Officer | 31/10/2021 |
| Baylor College of Medicine | Corporate Officer/Principal | - |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Training of Shannon Inman
| Texas A&M University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENPREX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Shannon Inman
